scholarly article | Q13442814 |
P50 | author | Willem Wisselink | Q130330099 |
P2093 | author name string | Tom Teerlink | |
Marlieke Visser | |||
Piet J. Kostense | |||
Milan C. Richir | |||
Bas A. J M. de Mol | |||
Paul A. M. van Leeuwen | |||
Heleen M. Oudemans-van Straaten | |||
Alexander P. J. Houdijk | |||
Mechteld A. R. Vermeulen | |||
P2860 | cites work | APACHE II: a severity of disease classification system | Q29547729 |
Asymmetric dimethylarginine, endothelial nitric oxide bioavailability and mortality in sepsis | Q31001162 | ||
Impact of the pulmonary artery catheter in critically ill patients: meta-analysis of randomized clinical trials | Q34456853 | ||
Immune-modulatory actions of arginine in the critically ill. | Q34564492 | ||
Plasma amino acid levels with a note on membrane transport: characteristics, regulation, and metabolic significance | Q34894810 | ||
Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock | Q35621102 | ||
The ratio of arginine to dimethylarginines is reduced and predicts outcomes in patients with severe sepsis* | Q35797087 | ||
HPLC analysis of ADMA and other methylated L-arginine analogs in biological fluids | Q36576359 | ||
Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury | Q37542333 | ||
The role of asymmetric dimethylarginine and arginine in the failing heart and its vasculature | Q37798082 | ||
Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock | Q42150089 | ||
Effect of preoperative oral immune-enhancing nutritional supplement on patients at high risk of infection after cardiac surgery: a randomised placebo-controlled trial | Q43733711 | ||
Early enteral nutrition in critically ill patients with a high-protein diet enriched with arginine, fiber, and antioxidants compared with a standard high-protein diet. The effect on nosocomial infections and outcome | Q43786240 | ||
Acute Escherichia coli endotoxaemia decreases the plasma l-arginine/asymmetrical dimethylarginine ratio in humans. | Q44068684 | ||
Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortality. | Q44294178 | ||
The asymmetrical dimethylarginine (ADMA)-multiple organ failure hypothesis | Q44294204 | ||
Early enteral immunonutrition in patients with severe sepsis: results of an interim analysis of a randomized multicentre clinical trial | Q44396495 | ||
Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase | Q44477052 | ||
Low arginine/asymmetric dimethylarginine ratio deteriorates systemic hemodynamics and organ blood flow in a rat model. | Q45721855 | ||
Metabolic profiling of arginine and nitric oxide pathways predicts hemodynamic abnormalities and mortality in patients with cardiogenic shock after acute myocardial infarction | Q46925513 | ||
The relationship between labour cost per patient and the size of intensive care units: a multicentre prospective study | Q47402757 | ||
Inhibition of nitric oxide synthesis causes myocardial ischemia in endotoxemic rats | Q50763903 | ||
Mortality predicted by APACHE II. The effect of changes in physiological values and post-ICU hospital mortality | Q51565910 | ||
Effects of L-arginine and L-nitro-arginine treatment on blood pressure and cardiac output in a rabbit endotoxin shock model | Q51639628 | ||
L-arginine pathway in the sepsis syndrome. | Q54231593 | ||
American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference | Q55879451 | ||
The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure | Q61661425 | ||
Early enteral administration of a formula (Impact) supplemented with arginine, nucleotides, and fish oil in intensive care unit patients: results of a multicenter, prospective, randomized, clinical trial | Q72588633 | ||
Measurement of nitrite and nitrate levels in plasma and urine — what does this measure tell us about the activity of the endogenous nitric oxite system? | Q74089846 | ||
Nitroglycerin in septic shock after intravascular volume resuscitation | Q78494402 | ||
In vivo arginine production and intravascular nitric oxide synthesis in hypotensive sepsis | Q79852136 | ||
Reduced citrulline production in sepsis is related to diminished de novo arginine and nitric oxide production | Q82838371 | ||
Analysis of asymmetric dimethylarginine in plasma by HPLC using a monolithic column | Q83125689 | ||
Arginine and sepsis: a question of the right balance? | Q84190610 | ||
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1458-1465 | |
P577 | publication date | 2011-12-01 | |
P1433 | published in | British Journal of Nutrition | Q4970206 |
P1476 | title | Imbalance of arginine and asymmetric dimethylarginine is associated with markers of circulatory failure, organ failure and mortality in shock patients | |
P478 | volume | 107 |
Q35903913 | "Immunonutrition" Has Failed to Improve Peritonitis-Induced Septic Shock in Rodents |
Q87065588 | ADMA levels and arginine/ADMA ratios reflect severity of disease and extent of inflammation after subarachnoid hemorrhage |
Q37602513 | Admission levels of asymmetric and symmetric dimethylarginine predict long-term outcome in patients with community-acquired pneumonia |
Q37187246 | Arginine appearance and nitric oxide synthesis in critically ill infants can be increased with a protein-energy–enriched enteral formula |
Q37220937 | Argininemia and plasma arginine bioavailability - predictive factors of mortality in the severe trauma patients? |
Q38597876 | Associations of Plasma Nitrite, L-Arginine and Asymmetric Dimethylarginine with Morbidity and Mortality in Patients with Necrotizing Soft Tissue Infections |
Q38635782 | Asymmetric Dimethylarginine Predicts Long-Term Outcome in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. |
Q36182184 | Asymmetric and Symmetric Dimethylarginine as Risk Markers for Total Mortality and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis of Prospective Studies |
Q37704715 | Asymmetric dimethylarginine and all-cause mortality: a systematic review and meta-analysis |
Q50091197 | Chronic Critical Illness: Application of What We Know. |
Q42916663 | Determination of homoarginine, arginine, NMMA, ADMA, and SDMA in biological samples by HPLC-ESI-mass spectrometry |
Q30236047 | Increased Dicarbonyl Stress as a Novel Mechanism of Multi-Organ Failure in Critical Illness |
Q38194032 | Increased circulatory asymmetric dimethylarginine and multiple organ failure: bile duct ligation in rat as a model |
Q41033479 | Markers of nitric oxide are associated with sepsis severity: an observational study |
Q35941757 | Nutrition before and during Surgery and the Inflammatory Response of the Heart: A Randomized Controlled Trial |
Q38172080 | Nutrition optimization prior to surgery |
Q39033973 | Parenteral or Enteral Arginine Supplementation Safety and Efficacy |
Q38138969 | Perspectives on the value of biomarkers in acute cardiac care and implications for strategic management |
Q38412077 | Pros and cons of feeding the septic intensive care unit patient |
Q41456914 | The Arginine/ADMA Ratio Is Related to the Prevention of Atherosclerotic Plaques in Hypercholesterolemic Rabbits When Giving a Combined Therapy with Atorvastatine and Arginine |
Q38851122 | When Is It Appropriate to Use Arginine in Critical Illness? |
Search more.